Dr. Margherita Alba Carlotta Pomatto received her Master’s Degree in Medical Biotechnology and PhD in Medical Physiopathology at the University of Turin in 2015 and 2018, respectively. She worked as a Post-doctoral fellow at the University of Turin in the Stem Cell Laboratory, Physiopathology of Atherosclerosis Laboratory, and Renal Immunopathology Laboratory. She co-founded EvoBiotech in 2019 and served as CEO until 2021. Her scientific activity has carried on in the fields of cell and stem cell biology, oncology, regenerative medicine, inflammation, and angiogenesis. She is an expert on extracellular vesicles as therapeutic agents, delivery systems, and diagnostic tools. She has extensive experience in the molecular characterization (protein and nucleic acid content) and the study of the biologic activities (e.g., angiogenesis, proliferation, migration, anti-oxidant activity) of extracellular vesicles derived from stem cells, biologic fluids (e.g., serum, plasma, saliva), and plants. She is a specialist in several techniques for loading extracellular vesicles with nucleic acids and other drugs.